Start Date: Oct 01, 2011
End Date: Sep 30, 2016
Mastitis is both the most prevalent infectious disease in dairy herds and the most costly disease for dairy producers. Older cost estimates for mastitis are in the neighborhood of $2 billion per year for producers. Antibiotics are the mainstay for mastitis treatment and control. Dairy cattle with mastitis receive more antibiotic therapy for its prevention and treatment than for all other dairy cattle diseases combined. Valid concerns by consumers regarding antibiotic usage need to be addressed by research on non-antibiotic alternatives. A more complete understanding of the bovine immune system will be a necessary component in the goal of greater understanding of non-antibiotic alternatives. A significant proportion of clinical mastitis cases occur in cows in the weeks shortly after calving when the cow’s innate immune system is compromised, highlighting the important role of a fully functional immune system in the fight against mastitis. Understanding of the bovine immune system is hampered by the lack of reagents that are available to other species, such as humans and mice. However, new technologies, such as RNA sequencing, do not depend on species-specific reagents and allow for the investigation of molecular interaction in a way not previously possible. Although many immune functions are similar between species, there are significant differences and these differences can have a profound impact on how a specific species reacts to a pathogen. It is the goal of this research project to determine the changes in gene and protein expression in bovine immune cells during an infection. In addition, this research will look at approaches to modulate the immune response in a way to enhance its ability to fight pathogens. The goals of the proposed research are to use a multi-discipline approach to: 1) Use RNA sequencing technology and proteomics to building a database of gene and protein expression data. To then model the expression data to molecular and cellular pathways that will lead to a better understanding of bovine innate immune responses to a mammary infection. 2) Advance our knowledge about the role of 25-hydroxyvitamin D3 [25(OH)D3] in maintaining innate immune function and test 25(OH)D3 as a non-antibiotic immune modulator of mammary innate immunity to reduce the severity and duration of an infection. Results of proposed research will be used to improve the model of bovine innate immune response by identifying novel signaling, transcriptional and post-transcriptional regulators of innate immunity.